» Articles » PMID: 37754897

Recent Advances in Stem Cell Differentiation Control Using Drug Delivery Systems Based on Porous Functional Materials

Overview
Date 2023 Sep 27
PMID 37754897
Authors
Affiliations
Soon will be listed here.
Abstract

The unique characteristics of stem cells, which include self-renewal and differentiation into specific cell types, have paved the way for the development of various biomedical applications such as stem cell therapy, disease modelling, and drug screening. The establishment of effective stem cell differentiation techniques is essential for the effective application of stem cells for various purposes. Ongoing research has sought to induce stem cell differentiation using diverse differentiation factors, including chemicals, proteins, and integrin expression. These differentiation factors play a pivotal role in a variety of applications. However, it is equally essential to acknowledge the potential hazards of uncontrolled differentiation. For example, uncontrolled differentiation can give rise to undesirable consequences, including cancerous mutations and stem cell death. Therefore, the development of innovative methods to control stem cell differentiation is crucial. In this review, we discuss recent research cases that have effectively utilised porous functional material-based drug delivery systems to regulate stem cell differentiation. Due to their unique substrate properties, drug delivery systems based on porous functional materials effectively induce stem cell differentiation through the steady release of differentiation factors. These ground-breaking techniques hold considerable promise for guiding and controlling the fate of stem cells for a wide range of biomedical applications, including stem cell therapy, disease modelling, and drug screening.

Citing Articles

Spatially controlled multicellular differentiation of stem cells using triple factor-releasing metal-organic framework-coated nanoline arrays.

Cho Y, Kang M, Park J, Eom Y, Kim T Nat Commun. 2025; 16(1):1389.

PMID: 39910083 PMC: 11799339. DOI: 10.1038/s41467-025-56373-0.


Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.

Hussen B, Hussen B, Taheri M, Yashooa R, Abdullah G, Abdullah S Int J Surg. 2024; 110(12):8002-8024.

PMID: 39497543 PMC: 11634165. DOI: 10.1097/JS9.0000000000002109.


Impact of 17β-Estradiol on the Shape, Survival, Osteogenic Transformation, and mRNA Expression of Gingiva-Derived Stem Cell Spheroids.

Kim J, Lee H, Song H, Park J Medicina (Kaunas). 2024; 60(1).

PMID: 38256321 PMC: 10817649. DOI: 10.3390/medicina60010060.

References
1.
Wu S, Mou C, Lin H . Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013; 42(9):3862-75. DOI: 10.1039/c3cs35405a. View

2.
Mora-Huertas C, Fessi H, Elaissari A . Polymer-based nanocapsules for drug delivery. Int J Pharm. 2009; 385(1-2):113-42. DOI: 10.1016/j.ijpharm.2009.10.018. View

3.
Xu C, Wang J, Zhu T, Shen Y, Tang X, Fang L . Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation. Curr Stem Cell Res Ther. 2015; 11(3):247-54. DOI: 10.2174/1574888x10666150723145707. View

4.
He S, Krippes K, Ritz S, Chen Z, Best A, Butt H . Ultralow-intensity near-infrared light induces drug delivery by upconverting nanoparticles. Chem Commun (Camb). 2014; 51(2):431-4. DOI: 10.1039/c4cc07489k. View

5.
Chen F, Zhang L, Chen Q, Zhang Y, Zhang Z . Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell. Chem Commun (Camb). 2010; 46(45):8633-5. DOI: 10.1039/c0cc02577a. View